HIGHLIGHTS
- who: M. Valiente from the Sanitaria Hospital Facultad de Medicina Madrid, Madrid, Spain have published the paper: Emerging targets for cancer treatment: S100A9/RAGE, in the Journal: (JOURNAL)
- what: The study showing the association of S100A9 levels in peripheral blood with the local control of the disease was retrospective and could not be controlled for other clinically relevant variables. The aim of this second study will be to evaluate whether RAGE inhibition improves the efficacy of radiotherapy in BM from various cancers.
SUMMARY
The authors recently demonstrated its contribution to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.